admin




InfYnity Biomarkers will participate at MEDICA 2019, world medical fair held in Dusseldorf, Germany. Come and meet us to see our offer for raw material and collaborative IVD work! For more information please contact: sales@infynity-biomarkers.com

MEDICA (November 18-21, 2019)



Infynity Biomarkers will present their new poster “A Novel High Performance Multiplex Immunoassay for the Serological Confirmation and Typing of HTLV infections” at the Third International Workshop on Human Endogenous Retroviruses and Diseases. It will take place at Cité des Congrès, Lyon - France.   We hope this will be […]

HERVS & Disease (November 5-6, 2019)



InfYnity Biomarkers is glad to announce that it will participate in a two-year, $594,008 Small Business Innovative Research (SBIR) grant, awarded to Kephera Diagnostics (Framingham, MA) and partners, by The National Institute of Allergy and Infectious Diseases, an agency of the National Institutes of Health (NIH). Chagas disease affects the […]

NIH Award to develop a Test-of-Cure for Chagas disease



Early this year, our Co-founder and Chief Scientific Officer, Dr. Maan Zrein, was invited to mentor an innovative project presented to the Arab’s world leading innovation reality show called “Stars of Science”. This program is supported by Qatar Foundation and aims at empowering junior scientists from the Arab world to […]

Stars of Science – Session 10 (2018)



InfYnity Biomarkers will be present at MEDICA 2018 in Düsseldorf, Germany. Come and meet us to learn about our products and expert Multiplex immunoassay service offer! For more information please contact: sales@infynity-biomarkers.com

MEDICA (November 12-15, 2018)



InfYnity Biomarkers is pleased to present an overview of its activities in the field of IVD and expert assay development. Our CSO, Maan Zrein will give special insights into our Multiplex immunoassay specialized services and explore the power of Artificial Intelligence for immune signatures recognition. Come with your ideas, we […]

Biotuesday (September 4, 2018)